Skip to main content

Table 2 Past 6 month receipt of alcohol treatment medications at baseline and follow-up by treatment group

From: Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial

Medication, n (%)

Integrated stepped alcohol treatment (n = 47)

Treatment as usual (n = 46)

p value

Any alcohol treatment medicationa

 Baseline

5 (10.6)

10 (21.7)

0.15

 Week 24

8 (17.0)

11 (23.9)

0.41

 Week 52

5 (10.6)

6 (13.0)

0.72

Disulfiram

 Baseline

0 (0)

0 (0)

NA

 Week 24

0 (0)

0 (0)

NA

 Week 52

0 (0)

0 (0)

NA

Acamprosate

 Baseline

0 (0)

0 (0)

NA

 Week 24

0 (0)

0 (0)

NA

 Week 52

0 (0)

0 (0)

NA

Naltrexone

 Baseline

0 (0)

0 (0)

NA

 Week 24

1 (2.1)

1 (2.2)

0.99

 Week 52

1 (2.1)

0 (0)

0.99

Topiramate

 Baseline

0 (0)

0 (0)

NA

 Week 24

0 (0)

0 (0)

NA

 Week 52

0 (0)

0 (0)

NA

Baclofen

 Baseline

1 (2.1)

2 (4.4)

0.62

 Week 24

2 (4.3)

2 (4.4)

0.99

 Week 52

2 (4.3)

1 (2.2)

0.99

Gabapentin

 Baseline

4 (8.5)

8 (17.4)

0.20

 Week 24

6 (12.8)

8 (17.4)

0.53

 Week 52

4 (8.5)

5 (10.9)

0.74

  1. aBased on receipt of disulfiram, acamprosate, naltrexone, topiramate, baclofen and/or gabapentin